| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $879,062 ) |
| | 2023 | 2023 | O-RAY PHARMA, INC. | 2285 E FOOTHILL BLVD | PASADENA | CA | 91107-3658 | LOS ANGELES | USA | R44AI167132 | IND-enabling Preclinical Development of Sustained Release Inner Ear Delivery of Corticosteroid | 000 | 2 | NIH | 11/8/2022 | $879,062 |
|
| Issue Date FY: 2022 ( Subtotal = $886,552 ) |
| | 2022 | 2022 | O-RAY PHARMA, INC. | 2285 E FOOTHILL BLVD | PASADENA | CA | 91107-3658 | LOS ANGELES | USA | R44AI167132 | IND-enabling Preclinical Development of Sustained Release Inner Ear Delivery of Corticosteroid | 000 | 1 | NIH | 12/21/2021 | $886,552 |
| | 2022 | 2022 | O-RAY PHARMA, INC. | 2285 E FOOTHILL BLVD | PASADENA | CA | 91107-3658 | LOS ANGELES | USA | R44AI167132 | IND-enabling Preclinical Development of Sustained Release Inner Ear Delivery of Corticosteroid | 001 | 1 | NIH | 6/1/2022 | $0 |
| | 2022 | 2020 | O RAY PHARMA INC | 2285 E FOOTHILL BLVD | PASADENA | CA | 91107-3658 | LOS ANGELES | USA | R44DC014416 | Prevention of Children's Tympanostomy Tube Otorrhea | 000 | 4 | NIH | 7/14/2022 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $284,456 ) |
| | 2020 | 2020 | O-RAY PHARMA | 2285 E FOOTHILL BLVD | PASADENA | CA | 91107-6825 | LOS ANGELES | USA | R44DC014416 | Prevention of Children's Tympanostomy Tube Otorrhea | 000 | 4 | NIH | 4/8/2020 | $284,456 |
| | 2020 | 2018 | O-RAY PHARMA, INC. | 2285 E FOOTHILL BLVD | PASADENA | CA | 91107-3658 | LOS ANGELES | USA | R43DC017415 | Inner ear therapeutics for sustained treatment of autoimmune inner ear disease | 000 | 1 | NIH | 11/20/2019 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $0 ) |
| | 2019 | 2017 | O-RAY PHARMA | 2285 E FOOTHILL BLVD | PASADENA | CA | 91107-6825 | LOS ANGELES | USA | R44DC014416 | Prevention of Children's Tympanostomy Tube Otorrhea | 000 | 3 | NIH | 9/17/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $169,214 ) |
| | 2018 | 2018 | O-RAY PHARMA | 2285 E FOOTHILL BLVD | PASADENA | CA | 91107-6825 | LOS ANGELES | USA | R43DC017415 | Inner ear therapeutics for sustained treatment of autoimmune inner ear disease | 000 | 1 | NIH | 7/30/2018 | $169,214 |
|
| Issue Date FY: 2017 ( Subtotal = $567,267 ) |
| | 2017 | 2017 | O-RAY PHARMA | 2285 E FOOTHILL BLVD | PASADENA | CA | 91107-6825 | LOS ANGELES | USA | R44DC014416 | Prevention of Children's Tympanostomy Tube Otorrhea | 000 | 3 | NIH | 5/17/2017 | $567,267 |
| | 2017 | 2015 | O-RAY PHARMA | 2285 E FOOTHILL BLVD | PASADENA | CA | 91107-6825 | LOS ANGELES | USA | R44DC008477 | Sustained Release Inner Ear Delivery of Corticosteroid | 000 | 5 | NIH | 9/14/2017 | $0 |
| | 2017 | 2015 | O-RAY PHARMA | 2285 E FOOTHILL BLVD | PASADENA | CA | 91107-6825 | LOS ANGELES | USA | R43DC014410 | Intratympanic delivery of biologics for treatment of autoimmune inner ear disease | 000 | 1 | NIH | 4/19/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $634,501 ) |
| | 2016 | 2016 | O-RAY PHARMA INC | 2181 EAST FOOTHILL BOULEVARD | PASADENA | CA | 91107 | LOS ANGELES | USA | R44DC014416 | Prevention of Children's Tympanostomy Tube Otorrhea | 000 | 2 | NIH | 6/17/2016 | $634,501 |
|
| Issue Date FY: 2015 ( Subtotal = $660,269 ) |
| | 2015 | 2015 | O-RAY PHARMA INC | 2181 EAST FOOTHILL BOULEVARD | PASADENA | CA | 91107 | LOS ANGELES | USA | R44DC008477 | Sustained Release Inner Ear Delivery of Corticosteroid | 000 | 5 | NIH | 5/12/2015 | $498,847 |
| | 2015 | 2015 | O-RAY PHARMA INC | 2181 EAST FOOTHILL BOULEVARD | PASADENA | CA | 91107 | LOS ANGELES | USA | R43DC014410 | Intratympanic delivery of biologics for treatment of autoimmune inner ear disease | 000 | 1 | NIH | 6/29/2015 | $161,422 |
| | 2015 | 2014 | O-RAY PHARMA INC | 2181 EAST FOOTHILL BOULEVARD | PASADENA | CA | 91107 | LOS ANGELES | USA | R43DC014416 | Prevention of Children's Tympanostomy Tube Otorrhea | 000 | 1 | NIH | 9/25/2015 | $0 |
|
| Issue Date FY: 2014 ( Subtotal = $998,424 ) |
| | 2014 | 2014 | O-RAY PHARMA INC | 2181 EAST FOOTHILL BOULEVARD | PASADENA | CA | 91107 | LOS ANGELES | USA | R44DC008477 | Sustained Release Inner Ear Delivery of Corticosteroid | 000 | 4 | NIH | 6/6/2014 | $839,147 |
| | 2014 | 2014 | O-RAY PHARMA INC | 2181 EAST FOOTHILL BOULEVARD | PASADENA | CA | 91107 | LOS ANGELES | USA | R43DC014416 | Prevention of Children's Tympanostomy Tube Otorrhea | 000 | 1 | NIH | 9/16/2014 | $159,277 |
| | 2014 | 2012 | O-RAY PHARMA INC | 2181 EAST FOOTHILL BOULEVARD | PASADENA | CA | 91107 | LOS ANGELES | USA | R43DC012265 | Ototoxicity protection with intratympanic steroid implant | 000 | 1 | NIH | 12/20/2013 | $0 |
|
| Issue Date FY: 2012 ( Subtotal = $154,472 ) |
| | 2012 | 2012 | O-RAY PHARMA INC | 2181 EAST FOOTHILL BOULEVARD | PASADENA | CA | 91107 | LOS ANGELES | USA | R43DC012265 | Ototoxicity protection with intratympanic steroid implant | 000 | 1 | NIH | 7/12/2012 | $154,472 |
|
| Issue Date FY: 2011 ( Subtotal = $535,685 ) |
| | 2011 | 2011 | O-RAY PHARMA INC | 2181 EAST FOOTHILL BOULEVARD | PASADENA | CA | 91107 | LOS ANGELES | USA | R44DC008477 | Sustained Release Inner Ear Delivery of Corticosteroid | 000 | 3 | NIH | 7/20/2011 | $535,685 |
|
| Issue Date FY: 2010 ( Subtotal = $535,685 ) |
| | 2010 | 2010 | O-RAY PHARMA INC | 2181 EAST FOOTHILL BOULEVARD | PASADENA | CA | 91107 | LOS ANGELES | USA | R44DC008477 | Sustained Release Inner Ear Delivery of Corticosteroid | 001 | 2 | NIH | 9/28/2010 | $0 |
| | 2010 | 2010 | O-RAY PHARMA INC | 2181 EAST FOOTHILL BOULEVARD | PASADENA | CA | 91107 | LOS ANGELES | USA | R44DC008477 | Sustained Release Inner Ear Delivery of Corticosteroid | 000 | 2 | NIH | 8/26/2010 | $535,685 |
|
|
